What Is Sapropterin?
Sapropterin, also known as Kuvan or tetrahyrdobiopterin (BH4), is the active form of tetrahydrobiopterin, a naturally occurring cofactor essential for several enzymatic reactions.[1]
How Does Sapropterin Act as a Cofactor?
Sapropterin serves as the primary cofactor for phenylalanine hydroxylase (PAH), the enzyme that converts phenylalanine to tyrosine in the liver. It enables this hydroxylation by donating electrons and accepting intermediates during the reaction cycle, preventing phenylalanine buildup in phenylketonuria (PKU).[1][2] Without sufficient BH4, PAH activity drops, leading to hyperphenylalaninemia.
Role in Other Enzyme Cofactor Functions
Beyond PAH, sapropterin acts as a cofactor for:
- Tyrosine hydroxylase, which produces L-DOPA for dopamine and norepinephrine synthesis.
- Tryptophan hydroxylase, which forms serotonin precursors.
- Nitric oxide synthase (NOS), generating nitric oxide for vascular function.[1][3]
These roles link sapropterin to neurotransmitter production, blood pressure regulation, and endothelial health.
Therapeutic Use in Cofactor Deficiency
Synthetic sapropterin treats BH4-responsive PKU by restoring cofactor levels, improving PAH function and lowering blood phenylalanine. Patients take it orally; responsiveness varies genetically, with 20-30% of PKU cases responding.[2][4]
What Limits Natural Cofactor Production?
Endogenous BH4 synthesis occurs via GTP cyclohydrolase I pathway, but defects in enzymes like dihydropteridine reductase cause deficiency. Sapropterin bypasses this by direct supplementation.[1]
When Does Sapropterin Fail as a Cofactor?
In non-responsive PKU, mutations impair PAH-BH4 binding despite supplementation. Overdosing risks side effects like headache or hypertension from excess nitric oxide.[4]
[1]: National Institutes of Health - Tetrahydrobiopterin
[2]: FDA Label - Kuvan (sapropterin)
[3]: Journal of Biological Chemistry - BH4 in Hydroxylases
[4]: New England Journal of Medicine - Sapropterin in PKU